Document Detail


Pharmacological therapy of cardiorenal syndromes and heart failure.
MedLine Citation:
PMID:  20428002     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Cardiorenal syndromes (CRS) are disorders of the heart and kidneys, whereby acute or chronic dysfunction in one organ may induce acute or chronic dysfunction of the other. The management of heart failure and CRS requires an understanding not only of the pathophysiology linking these two organ systems, but also an appreciation of the pharmacological effects of agents targeting one organ and their influence on the other. For instance, treatment of cardiovascular diseases and risk factors may influence, in a beneficial or harmful way, renal function and progression of renal injury. The same is true regarding management of renal disease and associated complications, where drug therapies may influence cardiac performance or modify risk of adverse cardiovascular outcome. In this chapter, pharmacological therapies in the management of patients with acute and chronic CRS are reviewed, novel regimens for prevention and treatment of worsening renal function in acute decompensated heart failure are discussed, and the need for high-quality future studies in this field is highlighted.
Authors:
Andrew A House
Publication Detail:
Type:  Journal Article; Review     Date:  2010-04-20
Journal Detail:
Title:  Contributions to nephrology     Volume:  164     ISSN:  1662-2782     ISO Abbreviation:  Contrib Nephrol     Publication Date:  2010  
Date Detail:
Created Date:  2010-04-29     Completed Date:  2010-08-13     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7513582     Medline TA:  Contrib Nephrol     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  164-72     Citation Subset:  IM    
Copyright Information:
Copyright 2010 S. Karger AG, Basel.
Affiliation:
Division of Nephrology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, Ont., Canada. andrew.house@lhsc.on.ca
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiovascular Agents / therapeutic use*
Heart Failure / drug therapy*,  epidemiology
Humans
Renal Insufficiency / drug therapy*,  epidemiology
Renin-Angiotensin System / drug effects*
Risk Factors
Water-Electrolyte Imbalance / drug therapy*,  epidemiology
Chemical
Reg. No./Substance:
0/Cardiovascular Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Diuretic therapy in fluid-overloaded and heart failure patients.
Next Document:  Extracorporeal Fluid Removal in Heart Failure Patients.